gentamicin has been researched along with Birth Weight in 56 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gentamicin clearance is decreased in neonates with HIE receiving hypothermia treatment compared to those not receiving hypothermia treatment." | 8.98 | Effect of hypothermia treatment on gentamicin pharmacokinetics in neonates with hypoxic-ischaemic encephalopathy: A systematic review and meta-analysis. ( An, SH; Choi, DW; Lee, SY; Park, JH, 2018) |
| "Birth weight, the 10-minute Apgar score and gentamicin were particularly associated with acute kidney injuries in our cohort." | 7.91 | Birth weight, Apgar scores and gentamicin were associated with acute kidney injuries in VLBW neonates requiring treatment for patent ductus arteriosus. ( Aygün, A; Ebrahimi-Fakhari, D; Gortner, L; Meyer, S; Poryo, M; Wagenpfeil, G; Wissing, A; Zemlin, M, 2019) |
| "Gentamicin peak and trough serum concentrations were collected from 139 neonates divided into three groups who were receiving one of the following intravenous 24-hour gentamicin regimens during the first 10 days of life, based on gestational age and birth weight (group 1, < 28 wks, 2." | 5.10 | A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. ( Cole, C; DiCenzo, R; Forrest, A; Guillet, R; Slish, JC, 2003) |
| "Fifty full term infants with birth weight of >/=2500 gm admitted to the neonatal intensive care unit of King Abdul-Aziz University Hospital, Jeddah, Kingdom of Saudi Arabia between November 1999 to October 2000 and received gentamicin at a dose of 2." | 5.10 | Once daily gentamicin dosing in full term neonates. ( Alsaedi, SA, 2003) |
| "Gentamicin clearance is decreased in neonates with HIE receiving hypothermia treatment compared to those not receiving hypothermia treatment." | 4.98 | Effect of hypothermia treatment on gentamicin pharmacokinetics in neonates with hypoxic-ischaemic encephalopathy: A systematic review and meta-analysis. ( An, SH; Choi, DW; Lee, SY; Park, JH, 2018) |
| "Birth weight, the 10-minute Apgar score and gentamicin were particularly associated with acute kidney injuries in our cohort." | 3.91 | Birth weight, Apgar scores and gentamicin were associated with acute kidney injuries in VLBW neonates requiring treatment for patent ductus arteriosus. ( Aygün, A; Ebrahimi-Fakhari, D; Gortner, L; Meyer, S; Poryo, M; Wagenpfeil, G; Wissing, A; Zemlin, M, 2019) |
| "Extended-interval dosing (EID) regimens of gentamicin have been validated for treating confirmed or suspected early- and late-onset sepsis in preterm infants in the first week of life." | 3.85 | Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age. ( Akierman, AR; Alshaikh, B; Dersch-Mills, D; Dobry, J; Sundaram, A; Yusuf, K, 2017) |
| "To characterize the extent that serum gentamicin concentrations are associated with hearing loss indicated by otoacoustic emission (OAE) screen failure in critically ill neonates receiving gentamicin in accordance with a high-dose, extended-interval dosing protocol." | 3.77 | Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life. ( Commers, AR; Cooper, AC; Finkelstein, M; Hoff, DS; Lipnik, PG; Tollefson, LM; Wilcox, RA, 2011) |
| "The initial dose of gentamicin 4 mg/kg for these critically ill premature and mature neonates with sepsis during the first week of life was high enough to reach bactericidal C(max,1) within 6-10 mg/L." | 3.76 | Tolerability and outcomes of kinetically guided therapy with gentamicin in critically ill neonates during the first week of life: an open-label, prospective study. ( Chládek, J; Chládková, J; Martínková, J; Pokorná, P; Selke-Krulichová, I; Vobruba, V; Záhora, J, 2010) |
| "Serum gentamicin concentration was measured in 31 newborn babies who received oral gentamicin for prophylaxis of necrotizing enterocolitis in order to determine the presence and degree of gastrointestinal absorption and its relationship to birth weight, gestational age, postnatal age and perinatal asphyxia." | 3.66 | Serum concentrations of gentamicin following oral administration to preterm newborns. ( Boehnert, J; Grylack, L; Scanlon, J, 1982) |
| " With the help of a generalizable model, an optimal dosage regimen was designed considering the important covariates of the identified model." | 2.82 | Pharmacometric approach to assist dosage regimen design in neonates undergoing therapeutic hypothermia. ( Lewis, LE; Mahadevan, R; Mallayasamy, S; Matcha, S; Raj, EA; Rajesh, V; Raju, AP, 2022) |
| " the number of dosing intervals) and to compare the number of serum concentrations outside the therapeutic range as an indicator of potential toxicity between the treatment groups." | 2.68 | Prospective, randomized, controlled evaluation of a gentamicin loading dose in neonates. ( Sankaran, K; Semchuk, W; Shevchuk, YM; Wallace, SM, 1995) |
| " The clearance (Cl), serum half-life (t(1/2)), and volume of distribution (Vd) of aminoglycosides change during the neonatal life, and the pharmacokinetics of aminoglycosides need to be studied in neonates in order to optimise therapy with these drugs." | 2.45 | Clinical pharmacokinetics of aminoglycosides in the neonate: a review. ( Pacifici, GM, 2009) |
| "44 kg dosing weight." | 1.56 | Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates. ( Faldasz, JD; Myers, SR; Yu, CZ, 2020) |
| "Appropriate dosing of gentamicin in critically ill neonates is still debated." | 1.56 | Dose Optimization of Gentamicin in Critically Ill Neonates. ( Al Jufairi, M; Elsegai, OAM; Qader, AM; Sridharan, K, 2020) |
| "Background: hearing disorders in the premature newborns impact on their development and language and therefore, on their quality of life." | 1.51 | Association between food insecurity and perinatal risk factors with hearing problems in preterm birth. ( Castillo-Chávez, AM; Hernández González, VH; Monroy-Torres, R, 2019) |
| " The prolonged half-life of gentamicin may need to be considered in dosing regimens for preterm SGA infants in the initial week of life." | 1.40 | Impact of small-for-gestational age (SGA) status on gentamicin pharmacokinetics in neonates. ( Edwards, D; Lulic-Botica, M; Natarajan, G; Sheer, T; Thomas, RL, 2014) |
| "This observational study conducted in a large cohort of newborns confirms the importance of body weight and gestational age for dosage adjustment." | 1.40 | Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates. ( Buclin, T; Csajka, C; Fuchs, A; Giannoni, E; Guidi, M; Werner, D; Widmer, N, 2014) |
| "To evaluate the pharmacokinetics of gentamicin in neonates with hypoxic ischemic encephalopathy (HIE) receiving hypothermia and to identify an empiric gentamicin dosing strategy in this population that optimizes achievement of target peak and trough concentrations." | 1.39 | Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. ( Bonifacio, SL; Frymoyer, A; Guglielmo, BJ; Meng, L; Verotta, D, 2013) |
| "This simplified, weight-based, extended-interval gentamicin dosing protocol for critically ill neonates was effective in achieving therapeutic peak plasma concentrations of gentamicin in most of the patients and, as a high proportion of patients had acceptable trough concentrations, may minimize the potential for toxicity." | 1.35 | Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates. ( Commers, AR; Hoff, DS; Lipnik, PG; Liu, M; Tollefson, LM; Wilcox, RA, 2009) |
| "A proper dosing regimen is fundamental when antibiotics with a low therapeutic index, as aminoglycosides (AMG), are used." | 1.34 | Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newborns. ( Del Zompo, M; Fanos, V; Martinelli, V; Mussap, M; Stronati, M; Testa, M, 2007) |
| "According to our pharmacokinetic population model, initial doses of gentamicin of 10 mg/kg, and dosage intervals between 36-48 h, appear to be appropriate to achieve target peak and trough serum levels of 15-20 and <0." | 1.32 | Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. ( Calvo, MV; Carbajosa, MT; Domínguez-Gil, A; Lanao, JM; Martín-Suárez, A; Mesa, JA; Miguelez, F, 2004) |
| " In addition neonate renal excretory function is low and the hepatic enzyme system is immature, thus the half-life of drugs is prolonged." | 1.30 | Pharmacokinetics of antibiotics in neonates. ( Sato, Y, 1997) |
| " The population model employed assumes the existence of residual variability in the serum concentrations and interindividual variability in the pharmacokinetic parameters." | 1.28 | Population pharmacokinetics of gentamicin in premature infants. ( Cervero, L; Domínguez-Gil, A; Izquierdo, M; Jimenez, NV; Lanao, JM, 1992) |
| " Gentamycin administration to premature neonates should be associated with monitoring of serum concentrations of the drug which would make individual adjustment of the dosage possible." | 1.28 | [Kinetics of gentamycin in premature infants with a low birth weight during the first four days of postnatal life]. ( Chládek, J; Chládková, J; Kopecká, J; Maresová, J; Martínková, J; Parízková, E; Tilser, I, 1992) |
| " Of 11 infants weighing between 1000 and 1500 g on an 18-hour dosing interval, 55% had trough serum gentamicin concentration of 2 mg/L or more." | 1.28 | Predictors of trough serum gentamicin concentrations in neonates. ( Johnson, CK; Keyes, PS; Rawlins, TD, 1989) |
| "Gentamicin absorption was measured after oral administration in 18 neonates treated prophylactically in an attempt to decrease the incidence of necrotizing enterocolitis." | 1.27 | Gentamicin absorption during prophylactic use for necrotizing enterocolitis. ( Driscoll, JM; James, LS; Mimms, GM; Miranda, JC; Rosen, TS; Schimmel, MS; Spinelli, W, 1984) |
| "The appropriate dosing of gentamicin in the newborn was evaluated." | 1.27 | Gentamicin dosage recommendations for neonates based on half-life predictions from birthweight. ( Charlton, CK; Kortas, K; Needelman, H; Thomas, RW, 1986) |
| "5 mg/Kg/dose) at various dosage intervals and t 1/2e was calculated using a one-compartment open model." | 1.27 | Gentamicin kinetics in the neonate. ( James, LS; Miranda, JC; Rosen, TS; Schimmel, MM; Spinelli, W, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (41.07) | 18.7374 |
| 1990's | 6 (10.71) | 18.2507 |
| 2000's | 11 (19.64) | 29.6817 |
| 2010's | 13 (23.21) | 24.3611 |
| 2020's | 3 (5.36) | 2.80 |
| Authors | Studies |
|---|---|
| Matcha, S | 1 |
| Raj, EA | 1 |
| Mahadevan, R | 1 |
| Raju, AP | 1 |
| Rajesh, V | 1 |
| Lewis, LE | 1 |
| Mallayasamy, S | 1 |
| Yu, CZ | 1 |
| Myers, SR | 1 |
| Faldasz, JD | 1 |
| Sridharan, K | 1 |
| Al Jufairi, M | 1 |
| Qader, AM | 1 |
| Elsegai, OAM | 1 |
| Sundaram, A | 1 |
| Alshaikh, B | 1 |
| Dersch-Mills, D | 1 |
| Dobry, J | 1 |
| Akierman, AR | 1 |
| Yusuf, K | 1 |
| Choi, DW | 1 |
| Park, JH | 1 |
| Lee, SY | 1 |
| An, SH | 1 |
| Aygün, A | 1 |
| Poryo, M | 1 |
| Wagenpfeil, G | 1 |
| Wissing, A | 1 |
| Ebrahimi-Fakhari, D | 1 |
| Zemlin, M | 1 |
| Gortner, L | 1 |
| Meyer, S | 1 |
| Castillo-Chávez, AM | 1 |
| Monroy-Torres, R | 1 |
| Hernández González, VH | 1 |
| Frymoyer, A | 1 |
| Meng, L | 1 |
| Bonifacio, SL | 1 |
| Verotta, D | 1 |
| Guglielmo, BJ | 1 |
| Lulic-Botica, M | 1 |
| Sheer, T | 1 |
| Edwards, D | 1 |
| Thomas, RL | 1 |
| Natarajan, G | 1 |
| Fuchs, A | 1 |
| Guidi, M | 1 |
| Giannoni, E | 1 |
| Werner, D | 1 |
| Buclin, T | 1 |
| Widmer, N | 1 |
| Csajka, C | 1 |
| Bateman, DA | 1 |
| Thomas, W | 1 |
| Parravicini, E | 1 |
| Polesana, E | 1 |
| Locatelli, C | 1 |
| Lorenz, JM | 1 |
| Berardi, A | 1 |
| Baroni, L | 1 |
| Bacchi Reggiani, ML | 1 |
| Ambretti, S | 1 |
| Biasucci, G | 1 |
| Bolognesi, S | 1 |
| Capretti, MG | 1 |
| Carretto, E | 1 |
| Ciccia, M | 1 |
| Fiorini, V | 1 |
| Fortini, C | 1 |
| Gargano, G | 1 |
| Pedna, MF | 1 |
| Rizzo, V | 1 |
| Creti, R | 1 |
| Ferrari, F | 1 |
| El-Kersh, TA | 1 |
| Marie, MA | 1 |
| Al-Sheikh, YA | 1 |
| Al-Agamy, MH | 1 |
| Al Bloushy, AA | 1 |
| Pacifici, GM | 1 |
| Hoff, DS | 2 |
| Wilcox, RA | 2 |
| Tollefson, LM | 2 |
| Lipnik, PG | 2 |
| Commers, AR | 2 |
| Liu, M | 1 |
| Guilbert, J | 1 |
| Meau-Petit, V | 1 |
| de Labriolle-Vaylet, C | 1 |
| Vu-Thien, H | 1 |
| Renolleau, S | 1 |
| Martínková, J | 2 |
| Pokorná, P | 1 |
| Záhora, J | 1 |
| Chládek, J | 2 |
| Vobruba, V | 1 |
| Selke-Krulichová, I | 1 |
| Chládková, J | 2 |
| Cooper, AC | 1 |
| Finkelstein, M | 1 |
| DiCenzo, R | 1 |
| Forrest, A | 1 |
| Slish, JC | 1 |
| Cole, C | 1 |
| Guillet, R | 1 |
| Alsaedi, SA | 1 |
| Lanao, JM | 2 |
| Calvo, MV | 1 |
| Mesa, JA | 1 |
| Martín-Suárez, A | 1 |
| Carbajosa, MT | 1 |
| Miguelez, F | 1 |
| Domínguez-Gil, A | 2 |
| Healy, DG | 1 |
| Wood, AE | 1 |
| Jafari, Z | 1 |
| Malayeri, S | 1 |
| Ashayeri, H | 1 |
| Basu, S | 1 |
| Kumar, A | 1 |
| Bhatia, BD | 1 |
| Crivaro, V | 1 |
| Bagattini, M | 1 |
| Salza, MF | 1 |
| Raimondi, F | 1 |
| Rossano, F | 1 |
| Triassi, M | 1 |
| Zarrilli, R | 1 |
| Testa, M | 1 |
| Fanos, V | 1 |
| Martinelli, V | 1 |
| Stronati, M | 1 |
| Mussap, M | 1 |
| Del Zompo, M | 1 |
| Miranda, JC | 2 |
| Schimmel, MS | 1 |
| Mimms, GM | 1 |
| Spinelli, W | 2 |
| Driscoll, JM | 1 |
| James, LS | 2 |
| Rosen, TS | 2 |
| Husson, C | 1 |
| Chevalier, JY | 1 |
| Jezequel, M | 1 |
| Mathe, JC | 1 |
| Costil, J | 1 |
| Aymard, P | 1 |
| Grylack, L | 1 |
| Boehnert, J | 1 |
| Scanlon, J | 1 |
| Friedman, CA | 1 |
| Parks, BR | 1 |
| Rawson, JE | 1 |
| Semchuk, W | 1 |
| Shevchuk, YM | 1 |
| Sankaran, K | 1 |
| Wallace, SM | 1 |
| Christo, GG | 1 |
| Shenoy, V | 1 |
| Matthai, J | 1 |
| Shivananda, PG | 1 |
| Venkatesh, A | 1 |
| Sato, Y | 1 |
| Ward, LC | 1 |
| Lingwood, BE | 1 |
| Coghlan, JP | 1 |
| Charles, BG | 1 |
| Colditz, PB | 1 |
| Aranda, JV | 1 |
| Cohen, S | 1 |
| Neims, AH | 1 |
| Reid, TM | 1 |
| González, RJ | 1 |
| Altirriba, O | 1 |
| Raspall, F | 1 |
| Demestre, X | 1 |
| Izquierdo, M | 1 |
| Cervero, L | 1 |
| Jimenez, NV | 1 |
| Kopecká, J | 1 |
| Tilser, I | 1 |
| Maresová, J | 1 |
| Parízková, E | 1 |
| Gibbs, RS | 1 |
| Duff, P | 1 |
| Keyes, PS | 1 |
| Johnson, CK | 1 |
| Rawlins, TD | 1 |
| Scheifele, DW | 1 |
| Ginter, GL | 1 |
| Olsen, E | 1 |
| Fussell, S | 1 |
| Pendray, M | 1 |
| MacKintosh, D | 1 |
| Baird-Lambert, J | 1 |
| Drage, D | 1 |
| Buchanan, N | 1 |
| Charlton, CK | 1 |
| Needelman, H | 1 |
| Thomas, RW | 1 |
| Kortas, K | 1 |
| Schimmel, MM | 1 |
| Koren, G | 1 |
| Leeder, S | 1 |
| Harding, E | 1 |
| Jacques, D | 1 |
| MacLeod, SM | 1 |
| Rosdahl, N | 2 |
| Andersen, JB | 2 |
| Wayne, ER | 1 |
| Burrington, JD | 1 |
| Pohland, F | 1 |
| Tosberg, P | 1 |
| Farmer, K | 1 |
| Hassall, IB | 1 |
| Roback, SA | 1 |
| Foker, J | 1 |
| Frantz, IF | 1 |
| Hunt, CE | 1 |
| Engel, RR | 1 |
| Leonard, AS | 1 |
| Bell, MJ | 1 |
| Kosloske, AM | 1 |
| Benton, C | 1 |
| Martin, LW | 1 |
| Paisley, JW | 1 |
| Smith, AL | 1 |
| Smith, DH | 1 |
| McCracken, GH | 1 |
| Jones, LG | 1 |
| Klein, JO | 1 |
| Herschel, M | 1 |
| Therakan, RM | 1 |
| Ingall, D | 1 |
| Vejlsgaard, R | 1 |
4 reviews available for gentamicin and Birth Weight
| Article | Year |
|---|---|
Pharmacometric approach to assist dosage regimen design in neonates undergoing therapeutic hypothermia.
Topics: Anti-Bacterial Agents; Birth Weight; Creatinine; Female; Gentamicins; Humans; Hypothermia, Induced; | 2022 |
Effect of hypothermia treatment on gentamicin pharmacokinetics in neonates with hypoxic-ischaemic encephalopathy: A systematic review and meta-analysis.
Topics: Birth Weight; Creatinine; Dose-Response Relationship, Drug; Female; Gentamicins; Gestational Age; Hu | 2018 |
Clinical pharmacokinetics of aminoglycosides in the neonate: a review.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Birth Weight; Drug Administration Schedule; Gentam | 2009 |
Progress in pathogenesis and management of clinical intraamniotic infection.
Topics: Amniotic Fluid; Ampicillin; Bacterial Infections; Birth Weight; Chorioamnionitis; Chromatography, Ga | 1991 |
4 trials available for gentamicin and Birth Weight
| Article | Year |
|---|---|
A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.
Topics: Algorithms; Anti-Bacterial Agents; Bayes Theorem; Birth Weight; Drug Administration Schedule; Gentam | 2003 |
Once daily gentamicin dosing in full term neonates.
Topics: Anti-Bacterial Agents; Birth Weight; Dose-Response Relationship, Drug; Gentamicins; Gestational Age; | 2003 |
Role of antibiotics in meconium aspiration syndrome.
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Birth Weight; Drug Therapy, Combination; | 2007 |
Prospective, randomized, controlled evaluation of a gentamicin loading dose in neonates.
Topics: Aging; Birth Weight; Creatinine; Dose-Response Relationship, Drug; Female; Gentamicins; Gestational | 1995 |
48 other studies available for gentamicin and Birth Weight
| Article | Year |
|---|---|
Simulated Comparison of a Bayesian Clinical Decision Support System Versus Standard of Care For Achieving Gentamicin Pharmacokinetic Targets in Neonates.
Topics: Anti-Bacterial Agents; Bayes Theorem; Birth Weight; Body Weight; Computer Simulation; Decision Suppo | 2020 |
Dose Optimization of Gentamicin in Critically Ill Neonates.
Topics: Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Birth Weight; Computer Simulation; Critical | 2020 |
Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age.
Topics: Anti-Bacterial Agents; Birth Weight; Body Weight; Drug Administration Schedule; Female; Gentamicins; | 2017 |
Birth weight, Apgar scores and gentamicin were associated with acute kidney injuries in VLBW neonates requiring treatment for patent ductus arteriosus.
Topics: Acute Kidney Injury; Apgar Score; Birth Weight; Ductus Arteriosus, Patent; Female; Gentamicins; Huma | 2019 |
Association between food insecurity and perinatal risk factors with hearing problems in preterm birth.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Birth Weight; Case-Control Studies; Educational Status; Fe | 2019 |
Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.
Topics: Anti-Bacterial Agents; Birth Weight; Creatinine; Dose-Response Relationship, Drug; Drug Administrati | 2013 |
Impact of small-for-gestational age (SGA) status on gentamicin pharmacokinetics in neonates.
Topics: Anti-Bacterial Agents; Birth Weight; Creatinine; Female; Gentamicins; Gestational Age; Half-Life; Hu | 2014 |
Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.
Topics: Anti-Bacterial Agents; Birth Weight; Body Weight; Cohort Studies; Computer Simulation; Dose-Response | 2014 |
Serum creatinine concentration in very-low-birth-weight infants from birth to 34-36 wk postmenstrual age.
Topics: Birth Weight; Body Temperature; Creatinine; Electrolytes; Female; Gentamicins; Gestational Age; Huma | 2015 |
The burden of early-onset sepsis in Emilia-Romagna (Italy): a 4-year, population-based study.
Topics: Ampicillin; Anti-Bacterial Agents; Birth Weight; Drug Resistance, Microbial; Escherichia coli; Esche | 2016 |
Prevalence and risk factors of early fecal carriage of Enterococcus faecalis and Staphylococcus spp and their antimicrobial resistant patterns among healthy neonates born in a hospital setting in central Saudi Arabia.
Topics: Anti-Bacterial Agents; Birth Weight; Carrier State; Cesarean Section; Delivery, Obstetric; Drug Resi | 2016 |
Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
Topics: Anti-Bacterial Agents; Birth Weight; Critical Illness; Drug Administration Schedule; Gentamicins; Ge | 2009 |
[Coagulase-negative staphylococcal osteomyelitis in preterm infants: a proposal for a diagnostic procedure].
Topics: Anti-Bacterial Agents; Bacteremia; Birth Weight; C-Reactive Protein; Cesarean Section; Child, Presch | 2010 |
Tolerability and outcomes of kinetically guided therapy with gentamicin in critically ill neonates during the first week of life: an open-label, prospective study.
Topics: Anti-Bacterial Agents; Birth Weight; Critical Illness; Drug Administration Schedule; Gentamicins; Ge | 2010 |
Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.
Topics: Anti-Bacterial Agents; Birth Weight; Critical Illness; Dose-Response Relationship, Drug; Drug Monito | 2011 |
Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
Topics: Algorithms; Anti-Bacterial Agents; Bayes Theorem; Birth Weight; Gentamicins; Gram-Negative Bacterial | 2004 |
Anterior mitral leaflet reconstruction with pericardium in a 1.9 kg infant with endocarditis.
Topics: Bioprosthesis; Birth Weight; Captopril; Combined Modality Therapy; Diseases in Twins; Diuretics; End | 2006 |
The ages of suspicion, diagnosis, amplification, and intervention in deaf children.
Topics: Age Distribution; Anti-Bacterial Agents; Birth Weight; Child, Preschool; Consanguinity; Cross-Sectio | 2007 |
Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
Topics: Acetyltransferases; Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; | 2007 |
Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newborns.
Topics: Anti-Bacterial Agents; Bacterial Infections; Birth Weight; Drug Monitoring; Drug Therapy, Combinatio | 2007 |
Gentamicin absorption during prophylactic use for necrotizing enterocolitis.
Topics: Birth Weight; Enterocolitis, Pseudomembranous; Gentamicins; Gestational Age; Humans; Infant, Newborn | 1984 |
Pharmacokinetic study of gentamicin in preterm and term neonates.
Topics: Birth Weight; Gentamicins; Gestational Age; Half-Life; Humans; Infant, Newborn; Infant, Premature; K | 1984 |
Serum concentrations of gentamicin following oral administration to preterm newborns.
Topics: Administration, Oral; Aging; Asphyxia Neonatorum; Birth Weight; Enterocolitis, Pseudomembranous; Gen | 1982 |
Gentamicin disposition in asphyxiated newborns: relationship to mean arterial blood pressure and urine output.
Topics: Asphyxia Neonatorum; Birth Weight; Blood Pressure; Gentamicins; Humans; Infant, Newborn; Kidney; Kin | 1982 |
Acinetobacter sepsis in neonates.
Topics: Acinetobacter; Birth Weight; Female; Gentamicins; Humans; India; Infant, Newborn; Male; Sepsis; Sex | 1993 |
Pharmacokinetics of antibiotics in neonates.
Topics: Anti-Bacterial Agents; Birth Weight; Cefotaxime; Ceftriaxone; Cephalosporins; Gentamicins; Humans; I | 1997 |
Is there advantage in using multiple frequency bioelectrical impedance analysis to predict gentamicin distribution volume in neonates?
Topics: Birth Weight; Body Composition; Electric Impedance; Extracellular Space; Gentamicins; Humans; Infant | 2000 |
Drug utilization in a newborn intensive care unit.
Topics: Ampicillin; Bicarbonates; Birth Weight; Canada; Chloramphenicol; Drug Therapy, Combination; Drug Uti | 1976 |
Emergence of group B streptococci in obstetric and perinatal infections.
Topics: Abortion, Septic; Birth Weight; Female; Fetal Death; Fever; Gentamicins; Gestational Age; Humans; In | 1975 |
[Infection in the low birth weight newborn (author's transl)].
Topics: Bacteria; Bacterial Infections; Birth Weight; Cephalothin; Female; Gentamicins; Humans; Infant, Newb | 1975 |
Population pharmacokinetics of gentamicin in premature infants.
Topics: Birth Weight; Gentamicins; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Models, Biol | 1992 |
[Kinetics of gentamycin in premature infants with a low birth weight during the first four days of postnatal life].
Topics: Birth Weight; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Prospective Studies | 1992 |
Predictors of trough serum gentamicin concentrations in neonates.
Topics: Birth Weight; Gentamicins; Gestational Age; Humans; Infant, Newborn; Intensive Care Units, Neonatal; | 1989 |
Comparison of two antibiotic regimens for neonatal necrotizing enterocolitis.
Topics: Ampicillin; Anti-Bacterial Agents; Birth Weight; Cefotaxime; Clinical Protocols; Drug Therapy, Combi | 1987 |
Effects of prenatal glucocorticoids on renal maturation in newborn infants.
Topics: Adult; beta 2-Microglobulin; Betamethasone; Birth Weight; Female; Gentamicins; Gestational Age; Glom | 1985 |
Gentamicin dosage recommendations for neonates based on half-life predictions from birthweight.
Topics: Bacterial Infections; Birth Weight; Drug Administration Schedule; Gentamicins; Gram-Negative Bacteri | 1986 |
Gentamicin kinetics in the neonate.
Topics: Bacterial Infections; Birth Weight; Enterocolitis, Pseudomembranous; Gentamicins; Gestational Age; H | 1985 |
Optimization of gentamicin therapy in very low birth weight infants.
Topics: Birth Weight; Drug Administration Schedule; Female; Gentamicins; Gestational Age; Half-Life; Humans; | 1985 |
Aspects of the pharmacology of gentamicin during the neonatal period.
Topics: Adult; Bacillus subtilis; Bilirubin; Biological Assay; Birth Weight; Erythroblastosis, Fetal; Female | 1973 |
Gastroschisis. A systemic approach to management.
Topics: Abdominal Muscles; Acid-Base Equilibrium; Ampicillin; Bacterial Infections; Bicarbonates; Birth Weig | 1973 |
[Proceedings: Controlled study on antibacterial chemoprophylaxis in newborn infants with umbilical vessel catheters].
Topics: Birth Weight; Carbenicillin; Catheterization; Cephalothin; Colistin; Gentamicins; Humans; Infant, Ne | 1974 |
An epidemic of E. Coli type 055:K59(B5) in a neonatal unit.
Topics: Administration, Oral; Birth Weight; Diarrhea, Infantile; Disease Outbreaks; Enterocolitis, Pseudomem | 1973 |
Necrotizing enterocolitis. An emerging entity in the regional infant intensive care facility.
Topics: Ampicillin; Apgar Score; Birth Weight; Catheterization; Disseminated Intravascular Coagulation; Ente | 1974 |
Neonatal necrotizing enterocolitis: prevention of perforation.
Topics: Birth Weight; Enterocolitis, Pseudomembranous; Female; Gentamicins; Humans; Infant, Newborn; Infant, | 1973 |
Gentamicin in newborn infants. Comparison of intramuscular and intravenous administration.
Topics: Bilirubin; Birth Weight; Blood Proteins; Female; Gentamicins; Gestational Age; Half-Life; Hematocrit | 1973 |
Gentamicin in the neonatal period.
Topics: Birth Weight; Escherichia coli; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Inf | 1970 |
Gentamicin in serious neonatal infections: absorption, excretion, and clinical results in 25 cases.
Topics: Bacterial Infections; Birth Weight; Drug Resistance; Escherichia coli; Female; Gentamicins; Humans; | 1971 |
Aspects of pharmacology of gentamicin in newborn infants.
Topics: Age Factors; Birth Weight; Blood Proteins; Female; Gentamicins; Gestational Age; Half-Life; Humans; | 1972 |